Chesley Taft & Associates’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.28M Sell
25,255
-2,545
-9% -$216K 0.09% 155
2026
Q1
$2.32M Buy
27,800
+1,401
+5% +$115K 0.1% 141
2025
Q4
$2.42M Buy
26,399
+1,139
+5% +$109K 0.1% 140
2025
Q3
$2.39M Buy
25,260
+10,215
+68% +$961K 0.1% 139
2025
Q2
$1.58M Buy
15,045
+2,423
+19% +$230K 0.07% 167
2025
Q1
$1.12M Buy
12,622
+3,897
+45% +$400K 0.05% 188
2024
Q4
$837K Buy
+8,725
New +$813K 0.04% 214

Other funds holding HQY

Chesley Taft & Associates's HQY Position: Q2 2026 in Review

Chesley Taft & Associates reduced its HealthEquity (HQY) stake by 9.2% in Q2 2026, selling an estimated $216K and leaving 25,255 shares worth $2.28M. The position accounts for 0.09% of the portfolio, ranked #155.

Chesley Taft & Associates first reported a position in HQY in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.42M in Q4 2025. 500 funds tracked by Wall St. Rank hold HQY as of Q2 2026.

  • Chesley Taft & Associates held 25,255 shares of HealthEquity worth $2.28M as of Q2 2026.
  • Chesley Taft & Associates sold 2,545 HealthEquity shares in Q2 2026, an estimated $216K.
  • HealthEquity made up 0.09% of Chesley Taft & Associates's portfolio in Q2 2026, its #155 holding.
  • Chesley Taft & Associates first reported a position in HealthEquity in Q4 2024 and has held it in 7 quarters since.
  • Chesley Taft & Associates's HealthEquity position peaked at $2.42M in Q4 2025.
  • 500 funds tracked by Wall St. Rank held HealthEquity as of Q2 2026.

Based on Chesley Taft & Associates's 13F filing for Q2 2026, filed 8 Jul 2026.